[1] Gopalakrishnan S, Van Emburgh BO, Robertson KD. DNA methylation in development and human disease. Mutat Res, 2008, 647(1-2): 30-38. <\p>

[2] Auclair G, Weber M. Mechanisms of DNA methylation and demethylation in mammals. Biochimie, 2012, 94(11): 2202-2211. <\p>

[3] Watt F, Molloy PL. Cytosine methylation prevents binding to DNA of a HeLa cell transcription factor required for optimal expression of the adenovirus major late promoter. Genes Dev, 1988, 2(9): 1136-1143. <\p>

[4] Zhu WG, Srinivasan K, Dai ZY, Duan WR, Druhan LJ, Ding HM, Yee L, Villalona-Calero MA, Plass C, Otterson GA. Methylation of adjacent CpG sites affects Sp1/Sp3 binding and activity in the p21(Cip1) promoter. Mol Cell Biol, 2003, 23(12): 4056-4065. <\p>

[5] Strahl BD, Allis CD. The language of covalent histone modifications. Nature, 2000, 403(6765): 41-45. <\p>

[6] Taverna SD, Li H, Ruthenburg AJ, Allis CD, Patel DJ. How chromatin-binding modules interpret histone modi-fications: lessons from professional pocket pickers. Nat Struct Mol Biol, 2007, 14(11): 1025-1040. <\p>

[7] Shi Y, Whetstine JR. Dynamic regulation of histone lysine methylation by demethylases. Mol Cell, 2007, 25(1): 1-14. <\p>

[8] Martin C, Zhang Y. The diverse functions of histone ly-sine methylation. Nat Rev Mol Cell Biol, 2005, 6(11): 838-849. <\p>

[9] Kouzarides T. Chromatin modifications and their function. Cell, 2007, 128(4): 693-705. <\p>

[10] Skreka K, Schafferer S, Nat IR, Zywicki M, Salti A, Apostolova G, Griehl M, Rederstorff M, Dechant G, Hüt-tenhofer A. Identification of differentially expressed non-coding RNAs in embryonic stem cell neural differen-tiation. Nucleic Acids Res, 2012, 40(13): 6001-6015. <\p>

[11] Kaikkonen MU, Lam MTY, Glass CK. Non-coding RNAs as regulators of gene expression and epigenetics. Cardiovasc Res, 2011, 90(3): 430-440. <\p>

[12] Mattick JS, Makunin IV. Non-coding RNA. Hum Mol Genet, 2006, 15(Suppl 1): R17-R29. <\p>

[13] Tuddenham L, Wheeler G, Ntounia-Fousara S, Waters J, Hajihosseini MK, Clark I, Dalmay T. The cartilage spe-cific microRNA-140 targets histone deacetylase 4 in mouse cells. Febs Lett, 2006, 580(17): 4214-4217. <\p>

[14] Fabbri M, Garzon R, Cimmino A, Liu ZF, Zanesi N, Cal-legari E, Liu SJ, Alder H, Costinean S, Fernan-dez-Cymering C, Volinia S, Guler G, Morrison CD, Chan KK, Marcucci G, Calin GA, Huebner K, Croce CM. Mi-croRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci USA, 2007, 104(40): 15805-15810. <\p>

[15] Kawasaki H, Taira K. Induction of DNA methylation and gene silencing by short interfering RNAs in human cells. Nature, 2004, 431(7005): 211-217. <\p>

[16] Aravin AA, Sachidanandam R, Girard A, Fejes-Toth K, Hannon GJ. Developmentally regulated piRNA clusters implicate MILI in transposon control. Science, 2007, 316(5825): 744-747. <\p>

[17] Yang PK, Kuroda MI. Noncoding RNAs and intranuclear positioning in monoallelic gene expression. Cell, 2007, 128(4): 777-786. <\p>

[18] Volkmar M, Dedeurwaerder S, Cunha DA, Ndlovu MN, Defrance M, Deplus R, Calonne E, Volkmar U, Igoillo- Esteve M, Naamane N, Del Guerra S, Masini M, Bugliani M, Marchetti P, Cnop M, Eizirik DL, Fuks F. DNA me-thylation profiling identifies epigenetic dysregulation in pancreatic islets from type 2 diabetic patients. Embo J, 2012, 31(6): 1405-1426. <\p>

[19] Kuroda A, Rauch TA, Todorov I, Ku HT, Al-Abdullah IH, Kandeel F, Mullen Y, Pfeifer GP, Ferreri K. Insulin gene expression is regulated by DNA methylation. PloS ONE, 2009, 4(9): e6953. <\p>

[20] Yang BT, Dayeh TA, Kirkpatrick CL, Taneera J, Kumar R, Groop L, Wollheim CB, Nitert MD, Ling C. Insulin pro-moter DNA methylation correlates negatively with insulin gene expression and positively with HbA(1c) levels in human pancreatic islets. Diabetologia, 2011, 54(2): 360- 367. <\p>

[21] Gilbert ER, Liu DM. Epigenetics: the missing link to un-derstanding beta-cell dysfunction in the pathogenesis of type 2 diabetes. Epigenetics, 2012, 7(8): 841-852. <\p>

[22] Ling C, Del Guerra S, Lupi R, Rönn T, Granhall C, Luthman H, Masiello P, Marchetti P, Groop L, Del Prato S. Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion. Diabetolo-gia, 2008, 51(4): 615-622. <\p>

[23] Sookoian S, Pirola CJ. DNA methylation and hepatic in-sulin resistance and steatosis. Curr Opin Clin Nutr Metab Care, 2012, 15(4): 350-356. <\p>

[24] Park JH, Stoffers DA, Nicholls RD, Simmons RA. Devel-opment of type 2 diabetes following intrauterine growth re-tardation in rats is associated with progressive epigenetic silencing of Pdx1. J Clin Invest, 2008, 118(6): 2316-2324. <\p>

[25] Jiang MH, Zhang YH, Liu M, Lan MS, Fei J, Fan WW, Gao X, Lu D. Hypermethylation of hepatic glucokinase and L-type pyruvate kinase promoters in high-fat diet- induced obese rats. Endocrinology, 2011, 152(4): 1284- 1289. <\p>

[26] Lenoir O, Flosseau K, Ma FX, Blondeau B, Mai A, Bas-sel-Duby R, Ravassard P, Olson EN, Haumaitre C, Scharfmann R. Specific control of pancreatic endocrine beta- and delta-cell mass by class IIa histone deacetylases HDAC4, HDAC5, and HDAC9. Diabetes, 2011, 60(11): 2861-2871. <\p>

[27] Chakrabarti SK, Francis J, Ziesmann SM, Garmey JC, Mirmira RG. Covalent histone modifications underlie the developmental regulation of insulin gene transcription in pancreatic beta cells. J Biol Chem, 2003, 278(26): 23617- 23623. <\p>

[28] Francis J, Chakrabarti SK, Garmey JC, Mirmira RG. Pdx-1 links histone H3-Lys-4 methylation to RNA po-lymerase II elongation during activation of insulin tran-scription. J Biol Chem, 2005, 280(43): 36244-36253. <\p>

[29] Deering TG, Ogihara T, Trace AP, Maier B, Mirmira RG. Methyltransferase Set7/9 maintains transcription and eu-chromatin structure at islet-enriched genes. Diabetes, 2009, 58(1): 185-193. <\p>

[30] McGee SL, van Denderen BJW, Howlett KF, Mollica J, Schertzer JD, Kemp BE, Hargreaves M. AMP-activated protein kinase regulates GLUT4 transcription by phos-phorylating histone deacetylase 5. Diabetes, 2008, 57(4): 860-867. <\p>

[31] Zhong L, D'Urso A, Toiber D, Sebastian C, Henry RE, Vadysirisack DD, Guimaraes A, Marinelli B, Wikstrom JD, Nir T, Clish CB, Vaitheesvaran B, Iliopoulos O, Kur-land I, Dor Y, Weissleder R, Shirihai OS, Ellisen LW, Espinosa JM, Mostoslavsky R. The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha. Cell, 2010, 140(2): 280-293. <\p>

[32] Lynn FC, Skewes-Cox P, Kosaka Y, McManus MT, Harfe BD, German MS. MicroRNA expression is required for pancreatic islet cell genesis in the mouse. Diabetes, 2007, 56(12): 2938-2945. <\p>

[33] Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma XS, Macdonald PE, Pfeffer S, Tuschl T, Rajewsky N, Rorsman P, Stoffel M. A pancreatic islet-specific microRNA regu-lates insulin secretion. Nature, 2004, 432(7014): 226-230. <\p>

[34] El OA, Baroukh N, Martens GA, Lebrun P, Pipeleers D, van Obberghen E. miR-375 targets 3'-phosphoinositide- dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic beta-cells. Diabetes, 2008, 57(10): 2708-2717. <\p>

[35] Lovis P, Gattesco S, Regazzi R. Regulation of the expres-sion of components of the exocytotic machinery of insu-lin-secreting cells by microRNAs. Biol Chem, 2008, 389(3): 305-312. <\p>

[36] Sakamoto H, Kogo Y, Ohgane J, Hattori N, Yagi S, Ta-naka S, Shiota K. Sequential changes in genome-wide DNA methylation status during adipocyte differentiation. Biochem Biophys Res Commun, 2008, 366(2): 360-366. <\p>

[37] Jiang YD, Liu ZH, Xiong JT, Jun C, Li GZ, Wang SR. Homocysteine-mediated PPARalpha, gamma DNA me-thylation and its potential pathogenic mechanism in monocytes. DNA Cell Biol, 2008, 27(3): 143-150. <\p>

[38] Fujiki K, Kano F, Shiota K, Murata M. Expression of the peroxisome proliferator activated receptor gamma gene is repressed by DNA methylation in visceral adipose tissue of mouse models of diabetes. BMC Biol, 2009, 7(1): 38. <\p>

[39] Noer A, Sørensen AL, Boquest AC, Collas P. Stable CpG hypomethylation of adipogenic promoters in freshly iso-lated, cultured, and differentiated mesenchymal stem cells from adipose tissue. Mol Biol Cell, 2006, 17(8): 3543-3556. <\p>

[40] Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM, Perry JR, Elliott KS, Lango H, Rayner NW, Shields B, Harries LW, Barrett JC, Ellard S, Groves CJ, Knight B, Patch AM, Ness AR, Ebrahim S, Lawlor DA, Ring SM, Ben-Shlomo Y, Jarvelin MR, So-vio U, Bennett AJ, Melzer D, Ferrucci L, Loos RJ, Bar-roso I, Wareham NJ, Karpe F, Owen KR, Cardon LR, Walker M, Hitman GA, Palmer CN, Doney AS, Morris AD, Smith GD, Hattersley AT, McCarthy MI. A common variant in the FTO gene is associated with body mass in-dex and predisposes to childhood and adult obesity. Sci-ence, 2007, 316(5826): 889-894. <\p>

[41] Gluckman PD. Epigenetics and metabolism in 2011: Epi-genetics, the life-course and metabolic disease. Nat Rev Endocrinol, 2011, 8(2): 74-76. <\p>

[42] Tateishi K, Okada Y, Kallin EM, Zhang Y. Role of Jhdm2a in regulating metabolic gene expression and obe-sity resistance. Nature, 2009, 458(7239): 757-761. <\p>

[43] Knutson SK, Chyla BJ, Amann JM, Bhaskara S, Huppert SS, Hiebert SW. Liver-specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networks. EMBO J, 2008, 27(7): 1017-1028. <\p>

[44] Wang LF, Xu SLY, Lee JE, Baldridge A, Grullon S, Peng WQ, Ge K. Histone H3K9 methyltransferase G9a re-presses PPARγ expression and adipogenesis. EMBO J, 2013, 32(1): 45-59. <\p>

[45] Elhanati S, Kanfi Y, Varvak A, Roichman A, Car-mel-Gross I, Barth S, Gibor G, Cohen HY. Multiple regulatory layers of SREBP1/2 by SIRT6. Cell Rep, 2013, 4(5): 905-912. <\p>

[46] Lin Q, Gao ZG, Alarcon RM, Ye JP, Yun Z. A role of miR-27 in the regulation of adipogenesis. FEBS J, 2009, 276(8): 2348-2358. <\p>

[47] Karbiener M, Fischer C, Nowitsch S, Opriessnig P, Papak C, Ailhaud G, Dani C, Amri EZ, Scheideler M. microRNA miR-27b impairs human adipocyte differentiation and targets PPARγ. Biochem Biophys Res Commun, 2009, 390(2): 247-251. <\p>

[48] Kim SY, Kim AY, Lee HW, Son YH, Lee GY, Lee JW, Lee YS, Kim JB. miR-27a is a negative regulator of adi-pocyte differentiation via suppressing PPARγ expression. Biochem Biophys Res Commun, 2010, 392(3): 323-328. <\p>

[49] Esau C, Davis S, Murray SF, Yu XX, Pandey SK, Pear M, Watts L, Booten SL, Graham M, McKay R, Subramaniam A, Propp S, Lollo BA, Freier S, Bennett CF, Bhanot S, Monia BP. miR-122 regulation of lipid metabolism re-vealed by in vivo antisense targeting. Cell Metab, 2006, 3(2): 87-98. <\p>

[50] Fernández-Hernando C, Suárez Y, Rayner KJ, Moore KJ. MicroRNAs in lipid metabolism. Curr Opin Lipidol, 2011, 22(2): 86-92.<\p>